US Patent Issued to Bristol-Myers Squibb on Sept. 29 for "Anti-CCR8 antibodies for treating cancer" (California, New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,296, issued on Sept. 29, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Anti-CCR8 antibodies for treating cancer" was invented by Ruth Yin-Zong Lan (Fremont, Calif.), Olufemi A. Adelakun (Kendall Park, N.J.), Ishita Barman (Millbrae, Calif.), Joseph Richard Campbell (Stanford, Calif.), SJ Jian Zhe Diong (San Mateo, Calif.), Felix Findeisen (San Francisco), Danielle M. Greenawalt (Philadelphia), Renu Jain (Redwood City, Calif.), Amy D. Jhatakia (Freemont, Calif.), John K. Lee (Alameda, Calif.), Peter Sung Keun Lee (Millbrae, Calif.), Linda Liang (Mountain View, Calif.), Kai Lu (Foster City, Calif.), Bryan McDonald (San Diego), Paul Blaine Mesko (Redwood City, Calif.)...